Deucravacitinib Uses, Dosage, Side Effects and more
Deucravacitinib is under investigation in clinical trial NCT04772079 (A Study to Evaluate the Drug Levels, Efficacy and Safety of BMS-986165 in Adolescent Participants With Moderate to Severe Plaque Psoriasis).
| Trade Name | Deucravacitinib |
| Generic | Deucravacitinib |
| Deucravacitinib Other Names | Deucravacitinib |
| Type | |
| Formula | C20H22N8O3 |
| Weight | Average: 425.467 Monoisotopic: 425.200316838 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
